These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy. Shimbo M Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131 [No Abstract] [Full Text] [Related]
3. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Froehner M Eur Urol; 2008 Aug; 54(2):368-9. PubMed ID: 18006213 [No Abstract] [Full Text] [Related]
4. Editorial comment on: diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per liter. Stephan C; Jung K Eur Urol; 2008 Aug; 54(2):369-70. PubMed ID: 18006212 [No Abstract] [Full Text] [Related]
5. Editorial comment on: Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels. Eggener S Eur Urol; 2009 Mar; 55(3):616. PubMed ID: 18639973 [No Abstract] [Full Text] [Related]
6. Editorial comment on: current applications for prostate-specific antigen doubling time. Gallina A; Karakiewicz PI Eur Urol; 2008 Aug; 54(2):302. PubMed ID: 19209421 [No Abstract] [Full Text] [Related]
7. Editorial comment on: current applications for prostate-specific antigen doubling time. Semjonow A Eur Urol; 2008 Aug; 54(2):301. PubMed ID: 19209420 [No Abstract] [Full Text] [Related]
8. Editorial comment on: current applications for prostate-specific antigen doubling time. O'Brien MF Eur Urol; 2008 Aug; 54(2):300-1. PubMed ID: 19209419 [No Abstract] [Full Text] [Related]
10. Editorial comment on: Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts. Moul JW; Tang P; Sun L Eur Urol; 2010 Mar; 57(3):452. PubMed ID: 19303696 [No Abstract] [Full Text] [Related]
18. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review. Malavaud B Eur Urol; 2008 Sep; 54(3):515-6. PubMed ID: 18585850 [No Abstract] [Full Text] [Related]
19. Editorial comment on: prostate-specific antigen kinetics in clinical decision-making during active surveillance for early prostate cancer--a review. Rittmaster R Eur Urol; 2008 Sep; 54(3):514-5. PubMed ID: 18585846 [No Abstract] [Full Text] [Related]